1. Home
  2. RYM vs MYO Comparison

RYM vs MYO Comparison

Compare RYM & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYM

RYTHM Inc.

N/A

Current Price

$17.92

Market Cap

39.1M

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$0.83

Market Cap

36.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RYM
MYO
Founded
2016
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Industrial Specialties
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
36.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RYM
MYO
Price
$17.92
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
7.3K
367.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.86
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$24.07
Revenue Next Year
N/A
$17.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$14.00
$0.64
52 Week High
$53.65
$6.27

Technical Indicators

Market Signals
Indicator
RYM
MYO
Relative Strength Index (RSI) 50.78 50.52
Support Level $14.83 $0.80
Resistance Level $20.30 $1.03
Average True Range (ATR) 1.85 0.06
MACD 0.22 0.01
Stochastic Oscillator 51.02 79.66

Price Performance

Historical Comparison
RYM
MYO

About RYM RYTHM Inc.

Rythm Inc is a USA Based company. The Company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: